Send to

Choose Destination
Asian J Androl. 2018 Sep 7. doi: 10.4103/aja.aja_70_18. [Epub ahead of print]

Lycopene exerts anti-inflammatory effect to inhibit prostate cancer progression.

Author information

Department of Surgery II, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
Department of Urology Surgery I, Cangzhou Central Hospital, Cangzhou 061000, China.


Lycopene is a natural compound that alleviates oxidative stress and inflammation, exerting therapeutic effects in a number of cancers. The aim of this study is to investigate the efficacy of lycopene in inhibiting prostate cancer. Cell viability assays indicated the dose- and time-dependent toxicity of lycopene in prostate cancer cells. Annexin V/propidium iodide double-staining assays revealed the strong apoptotic effects of lycopene. The levels of inflammatory factors, including interleukin-1 (IL1), IL6, IL8, and tumor necrosis factor-α (TNF-α), in lycopene-treated cells were also reduced by lycopene treatment. With the increasing dose of lycopene, the survival of mice bearing prostate cancer xenografts was significantly improved (P < 0.01), and the tumor burden was significantly reduced (P < 0.01). Our results indicate that lycopene is a promising chemotherapy drug, which inhibits prostate cancer progression by suppressing the inflammatory response.


dietary supplement; inflammation; lycopene; prostate cancer

Free full text

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd
Loading ...
Support Center